Foghorn Therapeutics, Inc. (FHTX)
2.08
-0.01
(-0.48%)
USD |
NASDAQ |
Oct 30, 16:00
2.085
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Cash and Short Term Investments (Annual) : 160.14M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 160.14M |
| December 31, 2024 | 243.75M |
| December 31, 2023 | 234.06M |
| December 31, 2022 | 345.80M |
| Date | Value |
|---|---|
| December 31, 2021 | 154.29M |
| December 31, 2020 | 185.77M |
| December 31, 2019 | 15.52M |
| December 31, 2018 | 40.02M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Anavex Life Sciences Corp. | 102.58M |
| Vaxcyte, Inc. | 1.561B |
| Connect Biopharma Holdings Ltd. | 44.34M |
| Caribou Biosciences, Inc. | 139.34M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |